Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on April 29, 2025
Aurora Spine Corporation Announces Fourth Quarter and Fiscal Year 2024 Financial Results
GlobeNewswire
·
April 29, 2025
-Company reports record revenue of $17.6 million for FY 2024, an increase of 21% – -Company to host conference call Today, Tuesday, April 29th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif …
Die Olon Group festigt ihre Führungsposition im Bereich Bioproduktion durch zwei strategische Ernennungen in Frankreich
GlobeNewswire
·
April 29, 2025
MAILAND, April 29, 2025 (GLOBE NEWSWIRE) -- Die Olon Group, ein weltweit führender CDMO-Anbieter im Pharmabereich, gibt die Ernennung von Jérôme Bédier zum CEO seiner französischen Unternehmen und von Andrea Conforto zum M…
Olon Group renforce son leadership dans la bioproduction avec deux nominations stratégiques en France
GlobeNewswire
·
April 29, 2025
MILAN, 29 avr. 2025 (GLOBE NEWSWIRE) -- Olon Group, acteur mondial de référence dans les services CDMO pharmaceutiques, annonce la nomination de Jérôme Bédier comme PDG de ses entités françaises, et d’Andrea Conforto comme vice-président M…
オロングループ (Olon Group) 、フランスにおける2件の戦略的な任命によりバイオ生産分野でのリーダーシップを強化
GlobeNewswire
·
April 29, 2025
ミラノ発, April 29, 2025 (GLOBE NEWSWIRE) -- 世界有数の製薬CDMOであるオロングループは、フランス法人のCEOにジェローム・ベディエ (Jérôme Bédier) を、バイオ医薬品向けCDMOサービスに特化した部門であるオロン・バイオテック (Olon Biotech) のM…
Olon Group Memperkukuh Kepimpinannya dalam Bioproduksi dengan Dua Pelantikan Strategik di Perancis
GlobeNewswire
·
April 29, 2025
MILAN, April 29, 2025 (GLOBE NEWSWIRE) -- Olon Group, sebuah CDMO farmaseutikal global terkemuka, mengumumkan pelantikan Jérôme Bédier sebagai Ketua Pegawai Eksekutif bagi entiti di Perancis dan Andrea Conforto sebagai Naib Presiden M…
Olon Group 在法国完成两项战略性任命，进一步巩固其在生物生产领域的领先地位
GlobeNewswire
·
April 29, 2025
米兰, April 29, 2025 (GLOBE NEWSWIRE) -- 全球领先的制药合同研发生产组织 (CDMO) Olon Group 宣布任命 Jérôme Bédier 为其法国子公司的首席执行官，同时任命 Andrea Conforto 担任旗下专注于生物制剂 CDMO 服务的业务部门——Olon Biotech CDMO 事业部的市场和销售副总裁。 上述任命进一步巩固了 Olon 在抗体药物偶联物 (ADC)、高活性原料药 (HPAPI) 及微生物生物生产领域拓展能力的战略布局。 ADC、 …
Olon Group 在法國的兩項戰略任命加強了其在生物製藥領域的領導地位
GlobeNewswire
·
April 29, 2025
米蘭, April 29, 2025 (GLOBE NEWSWIRE) -- 全球領先的藥物合同訂製研發和生產組織 (CDMO) 公司 Olon Group 宣布任命 Jérôme Bédier 為其法國實體的行政總裁，並任命 Andrea Conforto 為 Olon 生物技術部門的 CDMO 市場及銷售副總裁 (M…
Olon Group, 프랑스 법인 통해 두 명의 전략적 임원 선임으로 바이오 생산 분야 리더십 강화에 나서
GlobeNewswire
·
April 29, 2025
밀라노, April 29, 2025 (GLOBE NEWSWIRE) -- 글로벌 제약 CDMO (위탁개발생산) 기업인 Olon Group이 프랑스 법인의 CEO로 Jérôme Bédier를, 생물학적 제제 CDMO 서비스 전담 사업부인 Olon Biotech의 M…
Milliways, the chewing gum revolution, arrives in France
GlobeNewswire
·
April 29, 2025
Milliways, the fast-growing British plastic-free chewing gum brand, announces its launch in France with the ambition of transforming a market that has remained unchanged for decades. Already the leader of the “plastic-free” category in the UK, Milliways …
Milliways, la révolution du chewing-gum, débarque en France
GlobeNewswire
·
April 29, 2025
Milliways, la marque britannique de chewing-gum sans plastique en pleine expansion, annonce son lancement en France avec l’ambition de transformer un marché resté figé depuis des décennies. Déjà leader de la catégorie “plastic-free” au Royaume-Uni, …
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
GlobeNewswire
·
April 29, 2025
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene …
Aveanna to Participate at the RBC 2025 Global Healthcare Conference
GlobeNewswire
·
April 29, 2025
ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 …
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
GlobeNewswire
·
April 29, 2025
– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer – – TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery to baseline activities and overall …
Repligen Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 29, 2025
Revenue of $169 million, year-over-year increase of 10% as reported and 14% organic non-COVID growth Orders increased sequentially and high-teens year-over-year Adjusted operating income increased 72% year-over-year Reiterates 2025 full year organic …
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
GlobeNewswire
·
April 29, 2025
– ARCALYST® (rilonacept) Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth – – ARCALYST 2025 expected net product revenue increased to $590 - $605 million – – KPL-387 Phase 2/3 clinical trial in recurrent pericarditis on …
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
GlobeNewswire
·
April 29, 2025
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter …
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
GlobeNewswire
·
April 29, 2025
twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- …
Atsena Therapeutics to Present at May Scientific Conferences
GlobeNewswire
·
April 29, 2025
DURHAM, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced it will present at the following …
Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)
GlobeNewswire
·
April 29, 2025
twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- …
Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients
GlobeNewswire
·
April 29, 2025
MIAMI, April 29, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of …